Stem Cell therapy for Multiple Sclerosis (MS) to give patients real symptom relief from this progressive disease.

1. Motor Neuron Disease
Multiple sclerosis (MS) is an autoimmune condition
in which the immune system attacks the central
nervous system (CNS), leading to demyelination. It
may cause numerous physical and mental
symptoms, and often progresses to physical and
cognitive disability. Disease onset usually occurs in
young adults, and is more common in women.
MS affects the areas of the brain and spinal cord
known as the white matter. Specifically, MS destroys
oligodendrocytes, which are the cells responsible for
creating and maintaining the myelin sheath, which
helps the neurons carry electrical signals. MS results
in a thinning or complete loss of myelin and, less
frequently, transection of axons.
Type of MS:
Relapsing remitting MS (RRMS):
Periods of acute attacks with worsening of
symptoms followed by complete or partial recovery
(remission)
Secondary progressive MS (SPMS):
Following an initial period of relapsing remitting MS,
many people develop secondary progressive MS.
This is characterised by a gradual accumulation of
disability, either with or without relapses (relapsing
SPMS or non-relapsing SPMS).
Primary progressive MS (PPMS):
A gradual accumulation of disability from the
beginning, with no distinct periods of relapse and
remission.
Progressive-Relapsing MS:
In this relatively rare course of MS (5%), people
experience steadily worsening disease from the
beginning, but with clear attacks of worsening
neurologic function along the way.
StemCell Therapy for
Multiple Sclerosis
Multiple sclerosis (MS) is widely believed to be an
autoimmune condition – the body’s immune system
mistakenly attacks, and subsequently damages, the
‘myelin sheath’ protecting nerve cells in the brain and
spinal cord. This damage causes messages to and
from the brain to be slowed, distorted or stopped
altogether. This is what leads to the symptoms of MS.
This stem cell treatment is designed to target the
myelin sheath by introducing adult mesenchymal stem
cells past the blood brain barrier so they may
differentiate into and repair the myelin sheath nerve
cells. This process is called remyelination. Further,
being that Multiple Sclerosis is an auto-immune
condition, mesenchymal stem cells have the ability to
rebalance the immune system; keeping it from
attacking itself. This process is referred to as
immunomodulation. Through remyelination and
immunomodulation, we hope to work toward
improving the quality of lives of patients dealing with
Multiple Sclerosis.
Contact Us For a Free Consultation
contact@stemcells21.com | +6626507709
IntelliHealth+ Medical Centre
is our treatment facility in
Bangkok, Thailand.
www.stemcells21.com | www.IHSurgery.com